Vancouver, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The global endometrial ablation devices market size is expected to reach USD 1,963.32 Million at a steady revenue CAGR of 5.3% in 2032, according to latest analysis by Emergen Research. Increasing usage and preference for minimally invasive procedures among women suffering from endometrial and cervical cancers is fueling endometrial ablation devices market revenue growth.
Endometrial Ablation is a Minimally Invasive Procedure (MIS) that is deployed to mildly eliminate the thin uterus hormonal lining resulting in fewer complications, improved postoperative life quality, reduced stay at hospitals, and decrease in overall healthcare expenses. Growing number of postmenopausal women is as significant factor driving market revenue growth. Each year, around 25 million women pass through menopause and by 2030, it has been estimated that the global menopausal and postmenopausal women population will rise to 1.2 billion. Rising occurrence of gynecological conditions such as postmenopausal endometriosis is causative of surging demand for endometrial ablation procedures, and in turn, growth of the market.
However, concerns associated with design faults, malfunctions, and technical errors in endometrial ablation devices resulting in inappropriate patient treatment and management may hinder market growth over forecast period. Endometrial ablation procedures can lead to bleeding, pain, or infection, cold/heat damage caused to organs in vicinity, and uterine wall puncture injury occurring from surgical instruments that may restrain adoption of devices used in the procedure.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/765
Scope of Research
| Report Details | Outcome |
| Market size in 2020 | USD 1,049.9 Million |
| CAGR (2023–2032) | 5.3% |
| Revenue forecast to 2032 | USD 1,963.32 Million |
| Base year for estimation | 2020 |
| Historical data | 2018–2019 |
| Forecast period | 2023–2032 |
| Quantitative units | Revenue in USD Million and CAGR in % from 2023 to 2032. |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends. |
| Segments covered | Technology type, end-use, and region. |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa. |
| Country scope | U.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, Israel, Rest of MEA. |
| Key companies profiled | Boston Scientific Corporation, Olympus Corporation, Smith & Nephew plc. (Medtronic plc.), Idoman Teoranta, AEGEA Medical, Inc., CooperSurgical Inc., Richard Wolf GmbH, Hologic, Inc., Johnson & Johnson, and Minerva Surgical, Inc. |
| Customization scope | 10 hours of free customization and expert consultation. |
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/765
MAJOR COMPANIES and Competitive Landscape
The global endometrial ablation devices market is fragmented, with numerous small- and medium-sized players accounting for majority revenue share. Established companies are engaged in various research and development activities and initiatives to develop and deploy new and more efficient technologies and solutions in the endometrial ablation devices market. Some prominent players operating in the market are:
- Boston Scientific Corporation
- Olympus Corporation
- Smith & Nephew plc. (Medtronic plc.)
- Idoman Teoranta
- AEGEA Medical, Inc.
- CooperSurgical Inc.
- Richard Wolf GmbH
- Hologic, Inc.
- Johnson & Johnson
- Minerva Surgical, Inc.
Strategic Development
In February 2021, CooperSurgical announced the acquisition of California-based, AEGEA Medical and its FDA-approved Mara Water Vapor Ablation System. The acquisition complements CooperSurgical’s growing portfolio of women’s health medical products. Mara is an endometrial ablation treatment which uses water vapor to treat heavy menstrual bleeding. Mara has proven to reduce heavy menstrual bleeding and improve women’s quality of life effectively and safely.
In December 2020, Minerva Surgical announced the launch of complete suite of minimally invasive devices to support healthcare practitioners to treat abnormal uterine bleeding. The suite includes Genesys HTA Endometrial Ablation System, used by physicians that desires visualization within the uterine cavity during treatment, the growing ablation product the Minerva Endometrial Ablation System. It also includes Resectr device which removes endometrial polyps in the medical office setting and Symphion, the all-in-one tissue removal system which transforms how physicians remove uterine fibroids.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/765
Some Key Highlights From the Report
- Thermal balloon segment revenue is expected to register a rapid growth rate during the forecast period due to ease of usage and convenience of this type of product. It is a simple, safe, and effective technique for permanent treatment of dysfunctional uterine bleeding in selected cases. Four different types of thermal balloon devices available are cavaterm, thermachoice, thermablate, and menotreat.
- Hospital segment accounted for largest revenue share in 2020 revenue is expected to expand substantially over the forecast period due to availability of advanced endometrial ablation-based technologies in hospitals. Increasing incidence of endometrial ablation has encouraged hospitals to adopt related advanced technologies and devices. Moreover, emergence of hospitals that treat gynecological disorders and numerous reimbursement policies are factors expected to continue to drive growth of this segment.
- Asia Pacific market revenue is expected to expand at a rapid rate during the forecast period due to rising demand for endometrial ablation devices in developing countries such as India, China, and Brazil. Surge in prevalence of gynecological disorders, rise in awareness regarding healthcare devices among people, increasing per capita income, and growing investment in private healthcare sector will also contribute to market revenue growth.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/endometrial-ablation-devices-market
Emergen Research has segmented the global endometrial ablation devices market on the basis of technology type, end-use, and region:
- Technology Type Outlook (Revenue, USD Million; 2019–2032)
- Cryoablation
- Radiofrequency Ablation
- Hysteroscopic Ablation
- Thermal Balloon
- Hydrothermal Ablation
- Others
- End-use Outlook (Revenue, USD Million; 2019–2032)
- Ambulatory Surgery Center
- Hospital
- Clinic
- Regional Outlook (Revenue, USD Million; 2019–2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- Rest Of MEA
- North America
Curated Reports You Shouldn't Miss: Dive In Now!
Therapeutic Endoscopy Devices Market, By Product (Endoscope, Mechanical Endoscopic Equipment, and Others), By Hygiene (Single use, Sterilization, and Others), By Application, By End-Use, and By Region Forecast to 2032
Ultrasonic Dissection Market, By Product (Hand-Held Device, Ultrasonic Generators, and Accessories), By Application (General Surgery, Gynecology, Plastic Surgery, Urology, and Others), By End-Use, and By Region Forecast to 2032
Bone Conduction Hearing Systems Market, By Product Type (Bone Anchored Hearing Aids and Traditional Bone Conduction Hearing Aids), By Patient Type (Children/Pediatrics and Adults), By End-Use, and By Region Forecast to 2032
Image Guided Surgery Market, By Product (Image Guided Surgery Devices and Image Guided Surgery Software), By Application (Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, and Others), By End-Use, and By Region Forecast to 2032
Aortic Stent Grafts Market, By Product (Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft), By End-use [Hospitals, Specialty Clinics, and Ambulatory Surgical Centers (ASCs)], and By Region Forecast to 2032
Intraoperative Neurophysiological Monitoring Products Market, By Type (Systems and Accessories), By Modality, By Application, By End-use, and By Region Forecast to 2032
Teleoperation and Telerobotics Market, By Component (Hardware, Software, and Services), By Mechanism (Portable and Stationery), By Technology, By Application, By End-use, and By Region Forecast to 2032
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Explore Our Japanese Version: Endometrial Ablation Devices Market
Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights
Read our Press Release @ https://www.emergenresearch.com/press-release/global-endometrial-ablation-devices-market
